Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial

Intracranial Hemorrhage and Subsequent Ischemic Stroke in Patients With Atrial Fibrillation

(2015) Peter Brønnum Nielsen et al.   CHEST

Variation in Restarting Antithrombotic Drugs at Hospital Discharge After Intracerebral Hemorrhage

(2014) Marta Pasquini et al.   STROKE

Long-Term Outcome after Anticoagulation-Associated Intracerebral Haemorrhage with or without Restarting Antithrombotic Therapy

(2013) Celine S. Gathier et al.   CEREBROVASCULAR DISEASES

Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation

(2013) Lars Wallentin et al.   CIRCULATION

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Incidence of Oral Anticoagulant–Associated Intracerebral Hemorrhage in the Netherlands

(2013) Angel M.R. Schols et al.   STROKE

Unanswered questions and research priorities to optimise stroke prevention in atrial fibrillation with the new oral anticoagulants

(2013) Graeme J. Hankey   THROMBOSIS AND HAEMOSTASIS

Antithrombotic Therapy for Atrial Fibrillation

(2012) John J. You et al.   CHEST

Association of Aspirin Use With Major Bleeding in Patients With and Without Diabetes

(2012) Giorgia De Berardis et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Third Universal Definition of Myocardial Infarction

(2012) Kristian Thygesen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Thirty-Day Mortality After Ischemic Stroke and Intracranial Hemorrhage in Patients With Atrial Fibrillation On and Off Anticoagulants

(2012) Margaret C. Fang et al.   STROKE

Reinitiation of Anticoagulation After Warfarin-Associated Intracranial Hemorrhage and Mortality Risk: The Best Practice for Reinitiating Anticoagulation Therapy After Intracranial Bleeding (BRAIN) Study

(2011) Derek Yung et al.   CANADIAN JOURNAL OF CARDIOLOGY

Apixaban in Patients with Atrial Fibrillation

(2011) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Anticoagulant-Associated Intracerebral Hemorrhage

(2011) Matthew Flaherty   SEMINARS IN NEUROLOGY

Resumption of Oral Anticoagulation After Warfarin-Associated Intracerebral Hemorrhage

(2011) Sam Schulman   STROKE

The Dilemma of Resuming Anticoagulation After Intracranial Hemorrhage

(2011) Carlos A. Molina et al.   STROKE

Resumption of Oral Anticoagulation After Warfarin-Associated Intracerebral Hemorrhage

(2011) Thorsten Steiner   STROKE

Use of aspirin in Chinese after recovery from primary intracranial haemorrhage

(2011) Boon-Hor Chong et al.   THROMBOSIS AND HAEMOSTASIS

Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale

(2010) Renato D. Lopes et al.   AMERICAN HEART JOURNAL

Systematic Review of Observational Research Studying the Long-Term use of Antithrombotic Medicines Following Intracerebral Hemorrhage

(2010) Robert W.V. Flynn et al.   Cardiovascular Therapeutics

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST

Should anticoagulation be resumed after intracerebral hemorrhage?

(2010) J. N. GOLDSTEIN et al.   CLEVELAND CLINIC JOURNAL OF MEDICINE

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPEAN HEART JOURNAL

Management of anticoagulation following central nervous system hemorrhage in patients with high thromboembolic risk

(2010) G. W. J. HAWRYLUK et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy

(2010) A. Biffi et al.   NEUROLOGY

Optimal Timing of Resumption of Warfarin After Intracranial Hemorrhage

(2010) Ammar Majeed et al.   STROKE

Identifying Patients at High Risk for Stroke Despite Anticoagulation

(2010) Gregory Y.H. Lip et al.   STROKE

Guidelines for the Management of Spontaneous Intracerebral Hemorrhage

(2010) Lewis B. Morgenstern et al.   STROKE

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Restarting Anticoagulation Therapy After Warfarin-Associated Intracerebral Hemorrhage

(2008) Daniel O. Claassen et al.   ARCHIVES OF NEUROLOGY

Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment

(2008) Sam Schulman et al.   CHEST

Predictive Validity of a Medication Adherence Measure in an Outpatient Setting

(2008) Donald E. Morisky et al.   Journal of Clinical Hypertension

Ischaemic stroke subtypes and associated risk factors: a French population based study

(2008) Y Bejot et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY